Home
>
National Drug Code (NDC)
>
GaviLAX
GaviLAX - 43386-312-14 - (Polyethylene Glycol-3350)
Drug Information of GaviLAX
| Product NDC: | 43386-312 |
| Proprietary Name: | GaviLAX |
| Non Proprietary Name: | Polyethylene Glycol-3350 |
| Active Ingredient(s): | 17 g/1 & nbsp; Polyethylene Glycol-3350 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GaviLAX
| Product NDC: | 43386-312 |
| Labeler Name: | GAVIS Pharmaceuticals, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA091077 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091009 |
Package Information of GaviLAX
| Package NDC: | 43386-312-14 |
| Package Description: | 30 POWDER, FOR SOLUTION in 1 BOTTLE (43386-312-14) |
NDC Information of GaviLAX
| NDC Code | 43386-312-14 |
| Proprietary Name | GaviLAX |
| Package Description | 30 POWDER, FOR SOLUTION in 1 BOTTLE (43386-312-14) |
| Product NDC | 43386-312 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Polyethylene Glycol-3350 |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20091009 |
| Marketing Category Name | ANDA |
| Labeler Name | GAVIS Pharmaceuticals, LLC |
| Substance Name | POLYETHYLENE GLYCOL 3350 |
| Strength Number | 17 |
| Strength Unit | g/1 |
| Pharmaceutical Classes |
